![Jack Nielsen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jack Nielsen
Presidente presso
Biopharma Holding ApS
Profilo
Jack Bech Nielsen is currently Chairman at Biopharma Holding ApS.
Director at ALX Oncology Ltd. since 2020.
Director at Harmony Biosciences LLC since 2017.
Director at Vivo Co-Invest (S) LP.
Board Member at Ocelot Bio, Inc. since 2021.
Formerly Chairman at Alios BioPharma, Inc. from 2008 to 2014.
Independent Director at Harmony Biosciences Holdings, Inc. from 2017 to 2024.
Director at MediQuest Therapeutics, Inc. Independent Director at Reata Pharmaceuticals, Inc. from 2006 to 2022.
Director at Apollo Endosurgery, Inc. Director at PROCEPT BioRobotics Corp.
from 2015 to 2017.
Independent Director at ProteinSimple in 2014.
Director at Protein Forest, Inc. Director at Cardio-Optics, Inc. Director at Panacos Pharmaceuticals, Inc. Director at Nuevolution AB. Director at Neomend, Inc. Director at Tobira Therapeutics, Inc. Independent Director at Akebia Therapeutics, Inc. from 2014 to 2015.
Director at MacuLogix, Inc. from 2019 to 2022.
Director at Rainier Therapeutics, Inc. Director at Anokion SA from 2014 to 2017.
Director at Unchained Labs LLC from 2015 to 2017.
Director at Kanyos Bio, Inc. from 2015 to 2017.
Independent Director at Crinetics Pharmaceuticals, Inc. from 2017 to 2019.
Director at Apollo Endosurgery, Inc. from 2012 to 2017.
Independent Director at Instil Bio, Inc. from 2020 to 2024.
Independent Director at IO Biotech, Inc. from 2021 to 2024.
Independent Director at ALX Oncology Holdings, Inc. from 2020 to 2024.
Lead Independent Director at Aligos Therapeutics, Inc. from 2018 to 2024.
Managing Partner at Vivo Capital LLC from 2017 to 2025.
Senior Partner at Novo Nordisk A from 1990 to 2001.
Senior Partner at Novo Holdings A. Member-Supervisory Board at Merus NV from 2015 to 2017.
Senior Partner at Novo Ventures 1.
A from 2001 to 2017.
Partner at Novo Ventures (US), Inc. from 2006 to 2012.
Senior Partner at Novo Holdings A from 2001 to 2017.
Education includes a graduate degree from the Technical University of Denmark conferred in 1990.
Posizioni attive di Jack Nielsen
| Società | Posizione | Inizio |
|---|---|---|
Biopharma Holding ApS
 Biopharma Holding ApS MiscellaneousMiscellaneous Functions as an investment holding company | Presidente | - |
Alx Oncology Ltd.
 Alx Oncology Ltd. Pharmaceuticals: MajorHealth Technology Operates as biotechnology company developing immuno-oncology therapies for cancer | Direttore/Membro del Consiglio | 01/02/2020 |
Vivo Co-Invest (S) LP | Direttore/Membro del Consiglio | - |
Harmony Biosciences LLC
 Harmony Biosciences LLC Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies for people living with rare neurological disorders | Direttore/Membro del Consiglio | 01/09/2017 |
Ocelot Bio, Inc.
 Ocelot Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for patients with liver diseases | Direttore/Membro del Consiglio | 01/04/2021 |
Precedenti posizioni note di Jack Nielsen
| Società | Posizione | Fine |
|---|---|---|
Vivo Capital LLC
 Vivo Capital LLC Investment ManagersFinance Vivo Capital invests in both public and private middle-market companies located across the globe. The firm targets companies operating in the fields of biotechnology, pharmaceutical, healthcare and life sciences. It provides financing for early stage, growth stage, buyouts, spin-offs, and restructurings. The firm also acquires controlling interest. | Consulente / Consigliere | 01/08/2017 |
| HARMONY BIOSCIENCES HOLDINGS, INC. | Direttore/Membro del Consiglio | 27/06/2024 |
| ALIGOS THERAPEUTICS, INC. | Presidente | - |
| ALX ONCOLOGY HOLDINGS INC. | Direttore/Membro del Consiglio | 28/04/2024 |
| ░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Jack Nielsen
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
77
Relazioni di 1° grado
38
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 38 |
|---|---|
Vivo Capital LLC
Vivo Capital LLC Investment ManagersFinance Vivo Capital invests in both public and private middle-market companies located across the globe. The firm targets companies operating in the fields of biotechnology, pharmaceutical, healthcare and life sciences. It provides financing for early stage, growth stage, buyouts, spin-offs, and restructurings. The firm also acquires controlling interest. | Finance |
Novo Nordisk A/S
 Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
MediQuest Therapeutics, Inc.
 MediQuest Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of inflammatory skin diseases and conditions | Health Technology |
Reata Pharmaceuticals, Inc.
 Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics which regulates cellular metabolism and inflammation in serious neurologic diseases | Health Technology |
Apollo Endosurgery, Inc. /Old/
 Apollo Endosurgery, Inc. /Old/ Medical SpecialtiesHealth Technology Provides medical devices for treatment of obesity | Health Technology |
Alios BioPharma, Inc.
 Alios BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company which develops novel antiviral therapies for the treatment of respiratory diseases | Health Technology |
PROCEPT BioRobotics Corp.
 PROCEPT BioRobotics Corp. Medical SpecialtiesHealth Technology Develops robotic therapy systems for the treatment of lower urinary tract symptoms | Health Technology |
Novo Holdings A/S (Denmark)
 Novo Holdings A/S (Denmark) Investment ManagersFinance Functions as an alternative investment manager | Finance |
Technical University of Denmark
 Technical University of Denmark Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ProteinSimple
 ProteinSimple Medical SpecialtiesHealth Technology Develops and commercializes proprietary systems and consumables for protein analysis | Health Technology |
Protein Forest, Inc.
 Protein Forest, Inc. Packaged SoftwareTechnology Services Develops sample fractionation technology and bioinformatics software solutions | Technology Services |
Cardio-Optics, Inc.
 Cardio-Optics, Inc. Medical SpecialtiesHealth Technology Develops medical devices | Health Technology |
Panacos Pharmaceuticals, Inc.
 Panacos Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes small molecule drugs | Health Technology |
Nuevolution AB
 Nuevolution AB Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical products for treatment of oncology and chronic inflammatory diseases | Health Technology |
Neomend, Inc.
 Neomend, Inc. BiotechnologyHealth Technology Develops surgical wound healing products | Health Technology |
Tobira Therapeutics, Inc. /Old/
 Tobira Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company, which develops and commercializes antiviral products | Health Technology |
Akebia Therapeutics, Inc.
 Akebia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for kidney diseases | Health Technology |
Merus NV
 Merus NV BiotechnologyHealth Technology Discovers and develops therapeutics for cancer treatment | Health Technology |
Novo Ventures 1 A/S
 Novo Ventures 1 A/S Investment ManagersFinance Novo Ventures invests in companies located in Europe, the United States and Asia. The firm targets companies operating in the fields of health technology, health services, biotechnology and medical specialties sectors. It provides financing for early stage capital requirements. | Finance |
MacuLogix, Inc.
 MacuLogix, Inc. Medical/Nursing ServicesHealth Services Engages in diagnosis of dry age-related macular degeneration patients | Health Services |
Novo Ventures (US), Inc.
 Novo Ventures (US), Inc. Investment ManagersFinance Novo Ventures US invests venture capital in biotechnology and life science companies throughout the US and Europe. Their typical investments are as equity ranging from 1 to 15 million Euro. The firm may invest at any stage of development of a business idea - from seed capital over private placements to IPOs and public companies and they may invest in any part of the world. | Finance |
Rainier Therapeutics, Inc.
 Rainier Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company developing a targeted biologic for the potential treatment of both early stage and metastatic bladder cancer | Health Technology |
Anokion SA
 Anokion SA BiotechnologyHealth Technology Operates as a biotechnology company which develops therapies for antigen-specific immune tolerance | Health Technology |
Biopharma Holding ApS
Biopharma Holding ApS MiscellaneousMiscellaneous Functions as an investment holding company | Miscellaneous |
Unchained Labs
 Unchained Labs BiotechnologyHealth Technology Designs, develops and manufactures tools & devices for biologics and gene therapy research | Health Technology |
Alx Oncology Ltd.
Alx Oncology Ltd. Pharmaceuticals: MajorHealth Technology Operates as biotechnology company developing immuno-oncology therapies for cancer | Health Technology |
Kanyos Bio, Inc.
 Kanyos Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for type 1 diabetes | Health Technology |
Crinetics Pharmaceuticals, Inc.
 Crinetics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets therapeutics for endocrine-related diseases | Health Technology |
Apollo Endosurgery, Inc.
 Apollo Endosurgery, Inc. Medical SpecialtiesHealth Technology Develops and commercializes endoscopic devices for therapeutic endoscopy | Health Technology |
Novo Holdings A/S (Investment Company)
 Novo Holdings A/S (Investment Company) Financial ConglomeratesFinance Novo Holdings-IC aims to improve people’s health and the sustainability of society and the planet by generating attractive long-term returns on the assets of the Novo Nordisk Foundation. The firm invests in almost all life science segments including pharmaceuticals, biotechnology, medical technology, healthcare services and industrial BioSolutions. Outside of the life sciences they invest in a diversified portfolio of equities, fixed income, real assets and alternatives. | Finance |
Harmony Biosciences Holdings, Inc.
 Harmony Biosciences Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies for patients living with rare neurological disorders | Health Technology |
Harmony Biosciences LLC
Harmony Biosciences LLC Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies for people living with rare neurological disorders | Health Technology |
Instil Bio, Inc.
 Instil Bio, Inc. BiotechnologyHealth Technology Develops tumour infiltrating lymphocytes for the treatment of cancer | Health Technology |
Aligos Therapeutics, Inc.
 Aligos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops targeted, curative therapies for hepatologic diseases and viral infections | Health Technology |
ALX Oncology Holdings, Inc.
 ALX Oncology Holdings, Inc. BiotechnologyHealth Technology Operates as clinical stage immuno-oncology company, which develops therapies for cancer | Health Technology |
Ocelot Bio, Inc.
Ocelot Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for patients with liver diseases | Health Technology |
IO Biotech, Inc.
 IO Biotech, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel, immune-modulating cancer therapies | Health Technology |
Vivo Co-Invest (S) LP |
